BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,921,076 | +243.4% | 595,800 | +245.4% | 0.09% | +135.1% |
| Q2 2022 | $8,712,000 | -79.7% | 172,482 | -58.8% | 0.04% | -80.4% |
| Q3 2021 | $42,995,000 | +87.4% | 418,200 | +60.3% | 0.19% | +83.5% |
| Q2 2021 | $22,944,000 | +36.6% | 260,844 | +24.4% | 0.10% | +17.0% |
| Q4 2019 | $16,801,000 | -34.6% | 209,729 | -25.1% | 0.09% | -17.8% |
| Q1 2018 | $25,672,000 | +14.2% | 279,957 | -6.1% | 0.11% | +10.3% |
| Q4 2017 | $22,473,000 | +2.0% | 298,009 | -5.8% | 0.10% | -1.0% |
| Q3 2017 | $22,030,000 | +9.2% | 316,200 | -20.6% | 0.10% | -13.3% |
| Q2 2017 | $20,172,000 | +389.7% | 398,108 | +286.5% | 0.11% | +391.3% |
| Q1 2017 | $4,119,000 | – | 103,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
| DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
| Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
| Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
| CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
| Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
| Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
| Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
| Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
| EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |